LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 67.09 | 17.25 | 7406 | 5221 | 1.4185 | 1.0867 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 67.09 | 17.25 | 7693 | 5221 | 1.4735 | 1.0963 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 67.09 | 17.25 | 7780 | 5221 | 1.4901 | 1.0992 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 69.06 | 17.25 | 41 | 5242 | 0.0078 | 0.1107 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 69.06 | 17.25 | 7717 | 5242 | 1.4720 | 1.0960 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 69.06 | 17.25 | 7997 | 5242 | 1.5254 | 1.1051 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 69.06 | 17.25 | 8044 | 5242 | 1.5343 | 1.1066 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 71.03 | 17.25 | 42 | 5367 | 0.0078 | 0.1134 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 71.03 | 17.25 | 8034 | 5367 | 1.4969 | 1.0998 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 71.03 | 17.25 | 8029 | 5367 | 1.4960 | 1.0997 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 71.03 | 17.25 | 8286 | 5367 | 1.5439 | 1.1077 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 73.00 | 17.25 | 56 | 5546 | 0.0101 | 0.1519 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 73.00 | 17.25 | 8269 | 5546 | 1.4908 | 1.0982 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 73.00 | 17.25 | 8525 | 5546 | 1.5369 | 1.1059 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 73.00 | 17.25 | 8595 | 5546 | 1.5495 | 1.1080 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 74.97 | 17.25 | 57 | 5618 | 0.0101 | 0.1539 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 74.97 | 17.25 | 8551 | 5618 | 1.5218 | 1.1032 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 74.97 | 17.25 | 8799 | 5618 | 1.5660 | 1.1104 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 74.97 | 17.25 | 8893 | 5618 | 1.5827 | 1.1131 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 76.94 | 17.25 | 62 | 5681 | 0.0109 | 0.1653 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 76.94 | 17.25 | 8888 | 5681 | 1.5643 | 1.1099 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 76.94 | 17.25 | 9011 | 5681 | 1.5860 | 1.1134 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 76.94 | 17.25 | 9129 | 5681 | 1.6068 | 1.1167 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 78.91 | 17.25 | 56 | 5730 | 0.0098 | 0.1509 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 78.91 | 17.25 | 9171 | 5730 | 1.6004 | 1.1155 | MN20160310_N02 | K14 |